Latest / International Business with Fexingo: Global Trade, Cross-Border Deals, and Multinational Operations
How India Is Becoming the World's Generic Drug Factory
Episode 133 of International Business with Fexingo explores how India's pharmaceutical industry is emerging as the global hub for generic drugs, reshaping supply chains and trade dynamics. With the US trade deficit widening to $77.6 billion in May 2026 and a strong dollar pressuring exports, India's generic drug exports are surging, driven by cost advantages and regulatory approvals. We look at how companies like Sun Pharma and Dr. Reddy's are capturing market share from Western pharma giants, and what this means for drug pricing and global health security. The episode also…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.